Paper Details

  1. Home
  2. Paper Details

Viral kinetics and treatment response in patients with hepatitis C during induction and standard interferon therapy in combination with ribavirin.

Author: CarlssonT, ReichardO, WeilandO

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Short-term induction treatment with interferon (IFN) did not significantly improve the long-term outcome of hepatitis C virus (HCV) therapy, although a trend was observed. However, a rapid decline in viral load, particularly within the first day of treatment, is a strong predictor of sustained response.
Paper Details　
Original Abstract of the Article :
BACKGROUND: The early decline of hepatitis C virus (HCV) RNA levels during therapy may predict the outcome and can be utilized to improve treatment regimens. We studied the HCV RNA levels during induction and standard interferon (IFN) and ribavirin treatment. METHODS: Patients received IFN 3 MU dai...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/003655202760373461

データ提供：米国国立医学図書館（NLM）

Hepatitis C: Tracking Viral Kinetics to Guide Treatment

Hepatitis C virus (HCV) infection can lead to chronic liver disease, posing a significant threat to long-term health. This research examines the early decline of HCV RNA levels during treatment with interferon (IFN) and ribavirin as a potential predictor of treatment response. The study compared two treatment regimens: a short-term induction phase followed by standard IFN and ribavirin therapy, and standard IFN and ribavirin therapy from the outset. The authors investigated the relationship between the initial viral load decline and the likelihood of achieving a sustained viral response, a crucial measure of treatment success.

Viral Kinetics: A Window into Treatment Response

The study revealed a more pronounced initial viral load decline in patients who received the induction phase, particularly those infected with genotypes other than genotype 1. Furthermore, a significant correlation was observed between the magnitude of viral load decline at day 1 and the likelihood of achieving a sustained viral response. These findings suggest that early viral kinetics can provide valuable insights into the effectiveness of treatment and guide clinical decisions. It's like navigating a desert journey, where the initial direction of travel can significantly impact the ultimate destination.

A Glimpse into the Future of Hepatitis C Treatment

The study's findings highlight the importance of carefully monitoring viral kinetics during HCV treatment. By tracking the initial viral load decline, clinicians can better predict treatment response and personalize treatment regimens. This is a crucial step towards optimizing HCV treatment outcomes and ensuring the best possible chance for long-term viral suppression. It's a journey that requires vigilance and a focus on individual needs.

Dr.Camel's Conclusion

This research underscores the importance of understanding the nuances of viral kinetics in HCV treatment. It's a journey through the desert of viral infection, where the initial direction of travel can significantly impact the final destination. By carefully monitoring viral load decline, we can navigate this journey with a greater degree of precision and success. This knowledge is a vital tool in our quest to conquer this challenging disease.

Date :
  1. Date Completed 2003-02-25
  2. Date Revised 2019-08-14
Further Info :

Pubmed ID

12408530

DOI: Digital Object Identifier

10.1080/003655202760373461

Related Literature

Article Analysis
・Effective treatment of hepatitis c
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.